Schonfeld Strategic Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-63,700	Closed	-$584K	–	2667
2021 Q2	$584K	Buy	+63,700	New	+$371K	0.01%	1121

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Schonfeld Strategic Advisors's KIN Position: Q3 2021 in Review

Schonfeld Strategic Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 63,700 shares — an estimated $584K sold.

Schonfeld Strategic Advisors first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $584K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Schonfeld Strategic Advisors reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Schonfeld Strategic Advisors sold 63,700 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $584K.
Schonfeld Strategic Advisors first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
Schonfeld Strategic Advisors's Kindred Biosciences, Inc. position peaked at $584K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.